Authors:
Oostenbrink, JB
Tangelder, MJD
Busschbach, JJV
van Hout, BA
Buskens, E
Algra, A
Lawson, JA
Eikelboom, BC
Citation: Jb. Oostenbrink et al., Cost-effectiveness of oral anticoagulants versus aspirin in patients afterinfrainguinal bypass grafting surgery, J VASC SURG, 34(2), 2001, pp. 254-262
Citation: Jef. Zwart-van Rijkom et Ba. Van Hout, Cost-efficacy in interventional cardiology - Results from the EPISTENT study, EUR HEART J, 22(16), 2001, pp. 1476-1484
Authors:
Serruys, PW
Unger, F
Sousa, JE
Jatene, A
Bonnier, HJRM
Schonberger, JPAM
Buller, N
Bonser, R
van den Brand, MJB
van Herwerden, LA
Morel, MAM
van Hout, BA
Citation: Pw. Serruys et al., Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease., N ENG J MED, 344(15), 2001, pp. 1117-1124
Authors:
van Os, N
Niessen, LW
Bilo, HJG
Casparie, AF
van Hout, BA
Citation: N. Van Os et al., Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines, HEALTH POLI, 51(3), 2000, pp. 135-147
Authors:
Groener, MGH
van Ineveld, BM
Byttebier, G
van Hout, BA
Rutten, FFH
Citation: Mgh. Groener et al., An economic evaluation of Tomudex (raltitrexed) and 5-fluorouracil plus leucovorin in advanced colorectal cancer, ANTI-CANC D, 10(3), 1999, pp. 283-288
Authors:
De Laet, CEDH
van Hout, BA
Burger, H
Weel, AEAM
Hofman, A
Pols, HAP
Citation: Cedh. De Laet et al., Incremental cost of medical care after hip fracture and first vertebral fracture: The Rotterdam Study, OSTEOPOR IN, 10(1), 1999, pp. 66-72
Authors:
Busschbach, JJV
McDonnell, J
Essink-Bot, ML
van Hout, BA
Citation: Jjv. Busschbach et al., Estimating parametric relationships between health description and health valuation with an application to the EuroQol EQ-5D, J HEALTH EC, 18(5), 1999, pp. 551-571
Authors:
van Lent-Evers, NAEM
Mathot, RAA
Geus, WP
van Hout, BA
Vinks, AATMM
Citation: Naem. Van Lent-evers et al., Impact of goal-oriented and model-based clinical pharmacokinetic dosing ofaminoglycosides on clinical outcome: A cost-effectiveness analysis, THER DRUG M, 21(1), 1999, pp. 63-73